An interventional study of laparoscopic retrovesical colpopectinopexia in Pelvic Organ Prolapse, sponsored by Orel Regional Hospital, Russia. Status unknown at 1 site in Ukraine. Open to female participants. Per ClinicalTrials.gov, last updated 2016-09-30.
Sponsored by Orel Regional Hospital, Russia · Not applicable, Interventional, and Treatment
The purpose of this study is to identify whether a new operative technic would be acceptable in female with pelvic organ prolapse.
A new operative technic use to treat pelvic organ prolapse in women. Investigators plan to evaluate the results of procedure in the field of recurrence rate, effectiveness, mortality,morbidity and learning curves.
676 studies on the registry are indexed under Prolapse; 79 are open to participants now.
This study's planned enrollment of 70 is close to the median of 74 across 435 interventional studies indexed under Prolapse.
Browse Prolapse studies →This is the only study on the registry with Orel Regional Hospital, Russia as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
new operative technic
Procedure: laparoscopic retrovesical colpopectinopexia
Laparoscopic correction of pelvic organ prolapse using a mesh in retrovesical space with pectineal ligament fixation.
POP-Q assessment
assessment of vaginal wall accordion to POP-Q score
Time frame: first post operation day
POP-Q assessment
assessment of vaginal wall accordion to POP-Q score
Time frame: 6 month after operation
POP-Q assessment
assessment of vaginal wall accordion to POP-Q score
Time frame: 1 year after operation
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.